TimesSquare Capital Management, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 185 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.

Quarter-by-quarter ownership
TimesSquare Capital Management, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2022$15,580,000
-89.5%
243,899
-82.4%
0.18%
-86.7%
Q4 2021$148,597,000
-1.6%
1,387,330
-5.5%
1.32%
-0.1%
Q3 2021$150,981,000
+9.0%
1,468,545
-6.8%
1.32%
+16.3%
Q2 2021$138,545,000
-0.3%
1,575,095
+10.2%
1.13%
-4.8%
Q1 2021$138,948,000
-0.5%
1,429,070
+14.7%
1.19%
+4.9%
Q4 2020$139,672,000
+37.0%
1,245,405
+13.2%
1.13%
+18.7%
Q3 2020$101,983,000
+70.1%
1,100,135
+43.1%
0.96%
+67.0%
Q2 2020$59,970,000
+33.8%
768,850
+0.3%
0.57%
+6.9%
Q1 2020$44,828,000
-41.6%
766,545
-19.9%
0.54%
-21.8%
Q4 2019$76,700,000
+22.8%
957,430
+12.7%
0.68%
+23.9%
Q3 2019$62,436,000
-17.3%
849,820
+6.2%
0.55%
-5.0%
Q2 2019$75,466,000
+10.3%
800,020
-6.4%
0.58%
+10.2%
Q1 2019$68,412,000
+26.7%
854,620
-14.7%
0.53%
+13.1%
Q4 2018$53,998,000
-33.6%
1,001,640
-3.8%
0.47%
-13.5%
Q3 2018$81,264,000
+19.5%
1,041,040
-2.8%
0.54%
+18.5%
Q2 2018$67,983,000
-11.4%
1,070,940
+28.0%
0.46%
-12.8%
Q1 2018$76,696,000
-8.0%
836,375
-24.3%
0.52%
-4.6%
Q4 2017$83,345,000
+37.9%
1,105,230
+27.4%
0.55%
+35.1%
Q3 2017$60,453,000
+113.1%
867,700
+54.9%
0.40%
+121.3%
Q2 2017$28,375,000560,0000.18%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders